Why can't I see Olympia Pharmacy pricing before I commit?

The pricing transparency problem shows up at the worst moment: a patient is in front of you ready to start a hormone or peptide protocol, and you cannot tell them the cost because your platform does not show landed per-vial pricing. You either guess, quote a padded number to protect margin, or tell the patient you will follow up — and follow-ups are where conversions go to die. This played out most visibly in GLP-1 clinics when semaglutide and tirzepatide were available from compounders, but the same dynamic applies to testosterone programs, BHRT, and longevity peptide stacks where patients expect a number in the room.

For owners, the same opacity makes program pricing a moving target. If cost is only knowable after a clinical-liaison quote and can shift with volume tiers or contract renewal, building a predictable cash-pay program means working from estimates rather than confirmed numbers. The delay is not just minutes in the consult — it is the inability to finalize patient pricing for your whole formulary until the quote lands.

Olympia Pharmacy advertises volume-negotiated rates with no middleman markup — a legitimate value proposition backed by over 25 years of buying power across 503A and 503B compounding. Its provider page describes a clinical liaison onboarding, free BHRT consultant access, and co-branded marketing support. But those services come after you engage sales. Per-vial rates are not published on olympiapharmacy.com, so cost lives in a clinical-liaison conversation rather than on the catalog page. That is a deliberate model: negotiated rates require a negotiation.

When you evaluate this model, the right questions are about timing and visibility: how long from your first contact to a usable quote, whether per-vial rates appear inside the DrScript portal afterward, and how rates change as your volume moves between tiers. If pricing never surfaces in the ordering tool and must be looked up each time a new SKU comes up, the quote delay repeats across your formulary.

The delay disappears when pricing is visible at the point of decision. Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with the facilitation fee disclosed at payment, so a clinician can quote a patient in the room and an owner can model margin from real numbers the day they sign up. There is no clinical-liaison step between you and the cost of the medication you are about to order.

Pass-through pricing is the structural difference: instead of a negotiated rate hidden in a quote, you see the 503A cost and the disclosed fee. The evaluation test is whether you can answer 'what does this vial cost?' without sending an email or waiting for a callback. When the catalog answers that question, the consult keeps moving and pricing stops being a bottleneck — regardless of which pharmacy ultimately fulfills the order.